Easing a Burdened Healthcare System with Improved Cancer Diagnostics
Bob Rochelle, MBA
Innovative and sensitive testing methods will significantly cut down the load on clinical labs
Bob Rochelle, MBA
Bob Rochelle, MBA, is an expert in the launch, strategy, and marketing of novel healthcare products and is currently the chief commercial officer for Cleveland Diagnostics. With more than 30 years of experience, he has successfully launched pharmaceuticals, medical devices, and DNA-based diagnostics. Rochelle is currently applying his expertise to further Cleveland Diagnostics’ vision of bringing early cancer detection into everyday practice with advanced testing that is both simple and affordable.